Literature DB >> 15378006

The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression.

Kevin C Roche1, Nicola Wiechens, Tom Owen-Hughes, Neil D Perkins.   

Abstract

Smad nuclear interacting protein 1 (SNIP1) is an evolutionarily conserved protein containing a forkhead-associated (FHA) domain that regulates gene expression through interactions with multiple transcriptional regulators. Here, we have used short interfering RNAs (siRNAs) to knockdown SNIP1 expression in human cell lines. Surprisingly, we found that reduction in SNIP1 levels resulted in significantly reduced cell proliferation and accumulation of cells in the G1 phase of the cell cycle. Consistent with this result, we observed that cyclin D1 protein and mRNA levels were reduced. Moreover, SNIP1 depletion results in inhibition of cyclin D1 promoter activity in a manner dependent upon a previously characterized binding site for the AP-1 transcription factor family. SNIP1 itself is induced upon serum stimulation immediately prior to cyclin D1 expression. These effects were independent of the tumour suppressors p53 and retinoblastoma (Rb), but were consistent with an interaction with BRG1, a component of the ATP-dependent chromatin remodelling complex, Swi/Snf. These results define both a new function for SNIP1 and identify a previously unrecognized regulator of the cell cycle and cyclin D1 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378006     DOI: 10.1038/sj.onc.1208025

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

Review 1.  Regulation of senescence by microRNA biogenesis factors.

Authors:  Kotb Abdelmohsen; Subramanya Srikantan; Min-Ju Kang; Myriam Gorospe
Journal:  Ageing Res Rev       Date:  2012-01-28       Impact factor: 10.895

2.  Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.

Authors:  Katie Schumm; Sonia Rocha; Jorge Caamano; Neil D Perkins
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

3.  Regulation of cyclin D1 RNA stability by SNIP1.

Authors:  Cameron P Bracken; Steven J Wall; Benjamin Barré; Kostya I Panov; Paul M Ajuh; Neil D Perkins
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

4.  Smad nuclear interacting protein 1 (SNIP1) inhibits intestinal inflammation through regulation of epithelial barrier function.

Authors:  Y Shi; C He; C Ma; T Yu; Y Cong; W Cai; Z Liu
Journal:  Mucosal Immunol       Date:  2017-11-08       Impact factor: 7.313

5.  SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses.

Authors:  Sisi Liu; Jianyin Long; Bo Yuan; Mingjie Zheng; Mu Xiao; Jianming Xu; Xia Lin; Xin-Hua Feng
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

6.  Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor.

Authors:  Sonia Rocha; Michelle D Garrett; Kirsteen J Campbell; Katie Schumm; Neil D Perkins
Journal:  EMBO J       Date:  2005-03-10       Impact factor: 11.598

7.  SNIP1: a new activator of HSE signaling pathway.

Authors:  Qiang Li; Jian An; Xianghua Liu; Mingjun Zhang; Yichen Ling; Chenji Wang; Jing Zhao; Long Yu
Journal:  Mol Cell Biochem       Date:  2011-10-22       Impact factor: 3.396

Review 8.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

9.  Silencing of the Smad nuclear interacting protein 1 (SNIP1) by siRNA inhibits proliferation and induces apoptosis in pituitary adenoma cells.

Authors:  Xianzhen Chen; Fei Xue; Tianhao Xie; Chun Luo
Journal:  Tumour Biol       Date:  2013-07-30

10.  The FHA domain proteins DAWDLE in Arabidopsis and SNIP1 in humans act in small RNA biogenesis.

Authors:  Bin Yu; Liu Bi; Binglian Zheng; Lijuan Ji; David Chevalier; Manu Agarwal; Vanitharani Ramachandran; Wanxiang Li; Thierry Lagrange; John C Walker; Xuemei Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.